Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, GYP Haché, BRR Kesteleyn… - US Patent …, 2018 - Google Patents
3, 843, 662 A 10/1974 Holland 4, 569, 940 A 2/1986 Watts 4, 962, 101 A 10/1990 DiNinno et
al. 4, 995, 898 A 2/1991 Nasu et al. 5, 272, 167 A 12/1993 Girijavallabhan et al. 5, 308, 826 …
al. 4, 995, 898 A 2/1991 Nasu et al. 5, 272, 167 A 12/1993 Girijavallabhan et al. 5, 308, 826 …
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, SJ Last, G Rombouts… - US Patent …, 2020 - Google Patents
9066932 B2 6/20 15 Hartman et al. 2 () 16/()() 51 5 12 A1 2/2016 Vandyck et al. 9,115, 101
B2 8/20 15 Bodil Van Niel et al. 2 () 16/()() 83383 A| 3/20 16 Guo et al. RE45, 670 E 9/20 15 …
B2 8/20 15 Bodil Van Niel et al. 2 () 16/()() 83383 A| 3/20 16 Guo et al. RE45, 670 E 9/20 15 …
Hepatitis B antiviral agents
GD Hartman, OA Flores - US Patent 10,196,376, 2019 - Google Patents
ZVCMXSGELBZKBV-UHFFFAOYSA-N CC1= C (F) C= CC (NC (= O) C2= CC (S (= O)(= O)
N3CCCCC3CO)= CC= C2)= C1 Chemical compound CC1= C (F) C= CC (NC (= O) C2= CC …
N3CCCCC3CO)= CC= C2)= C1 Chemical compound CC1= C (F) C= CC (NC (= O) C2= CC …
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, GYP Haché, SJ Last… - US Patent …, 2018 - Google Patents
5, 585, 327 A 5, 607, 929 A 5, 708, 034 A 5, 723, 411 A 5, 756, 524 A 5, 795, 907 A 5, 912,
260 A 5, 919, 970 A 5, 939, 423 A 6, 025, 367 A 6, 265, 408 B1 6, 476, 025 B1 6, 650, 463 …
260 A 5, 919, 970 A 5, 939, 423 A 6, 025, 367 A 6, 265, 408 B1 6, 476, 025 B1 6, 650, 463 …
N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, GYP Haché, SJ Last… - US Patent …, 2018 - Google Patents
5, 723, 411 A 3/1998 Stevenson et al. 5, 756, 524 A 5/1998 Riordan et al. 5, 795, 907 A
8/1998 Kalindjian et al. 5, 912, 260 A 6/1999 Kalindjian et al. 5, 919, 970 A 7/1999 Song et …
8/1998 Kalindjian et al. 5, 912, 260 A 6/1999 Kalindjian et al. 5, 919, 970 A 7/1999 Song et …
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, GYP Haché, SJ Last, DC Mc Gowan… - US Patent …, 2018 - Google Patents
2015-11-18 Assigned to JANSSEN INFECTIOUS DISEASES BVBA reassignment JANSSEN
INFECTIOUS DISEASES BVBA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
INFECTIOUS DISEASES BVBA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, SJ Last, PJMB Raboisson - US Patent 10,125,094, 2018 - Google Patents
US10125094B2 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment
of hepatitis B - Google Patents US10125094B2 - Sulfamoyl-arylamides and the use thereof as …
of hepatitis B - Google Patents US10125094B2 - Sulfamoyl-arylamides and the use thereof as …
Discovery and optimization of 2, 4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors
The results of a high-throughput screening assay using the DENV-2 replicon showed that
the 2, 4-diaminoquinazoline derivative 4a has a high dengue virus inhibitory activity (EC50 …
the 2, 4-diaminoquinazoline derivative 4a has a high dengue virus inhibitory activity (EC50 …
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
K Vandyck, BRR Kesteleyn, SMA Pieters… - US Patent …, 2019 - Google Patents
6, 476, 025 B1 11/2002 Gutterer 6, 650, 463 B2 11/2003 Obikawa et al. 6, 668, 527 B2
12/2003 Duplantier et al. 6, 780, 389 B2 8/2004 Karl et al. 7, 115, 595 B2 10/2006 …
12/2003 Duplantier et al. 6, 780, 389 B2 8/2004 Karl et al. 7, 115, 595 B2 10/2006 …
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
SMH Vendeville, SJ Last, SD Demin… - US Patent …, 2020 - Google Patents
2019-09-20 Assigned to JANSSEN INFECTIOUS DISEASES BVBA reassignment JANSSEN
INFECTIOUS DISEASES BVBA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …
INFECTIOUS DISEASES BVBA ASSIGNMENT OF ASSIGNORS INTEREST (SEE …